nitrendipine has been researched along with Cardiomyopathies in 7 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ryanodine is a significantly less potent negative inotrope in isolated papillary muscles prepared from 1-2-month-old BIO 14." | 1.28 | Radioligand binding and inotropic effects of ryanodine in the cardiomyopathic Syrian hamster. ( Finkel, MS; Oddis, CV; Romeo, RC; Salama, G; Shen, L, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SL | 1 |
| Ostadalova, I | 1 |
| Kolar, F | 1 |
| Dhalla, NS | 1 |
| Finkel, MS | 3 |
| Shen, L | 1 |
| Romeo, RC | 1 |
| Oddis, CV | 1 |
| Salama, G | 1 |
| Howlett, SE | 2 |
| Gordon, T | 2 |
| Marks, ES | 2 |
| Patterson, RE | 2 |
| Speir, EH | 2 |
| Steadman, K | 1 |
| Keiser, HR | 2 |
| Steadman, KA | 1 |
| Rafuse, VF | 1 |
| Nahas, G | 1 |
| Trouve, R | 1 |
| Maillet, M | 1 |
7 other studies available for nitrendipine and Cardiomyopathies
| Article | Year |
|---|---|
Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy.
Topics: Animals; Blood Glucose; Brain; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cardiomyopat | 1992 |
Radioligand binding and inotropic effects of ryanodine in the cardiomyopathic Syrian hamster.
Topics: Animals; Calcium Channels; Cardiomyopathies; Cricetinae; Depression, Chemical; Mesocricetus; Myocard | 1992 |
[3H]-nitrendipine binding in normal and cardiomyopathic hamster hearts: modulation by temperature, verapamil and diltiazem.
Topics: Allosteric Regulation; Animals; Binding Sites; Calcium Channels; Cardiomyopathies; Cricetinae; Dihyd | 1990 |
Increased cardiac calcium channels in hamster cardiomyopathy.
Topics: Animals; Calcium; Calcium Channels; Cardiomyopathies; Cricetinae; Ion Channels; Kinetics; Mesocricet | 1986 |
Correlation of changes in cardiac calcium channels with hemodynamics in Syrian hamster cardiomyopathy and heart failure.
Topics: Animals; Body Weight; Calcium; Cardiomyopathies; Cricetinae; Heart Failure; Hemodynamics; Humans; In | 1987 |
[3H]-nitrendipine binding sites in normal and cardiomyopathic hamsters: absence of a selective increase in putative calcium channels in cardiomyopathic hearts.
Topics: Animals; Binding Sites; Calcium Channels; Cardiomyopathies; Cricetinae; Male; Mesocricetus; Muscular | 1988 |
[Prevention of the cardiotoxicity of cocaine using a calcium blocker].
Topics: Animals; Cardiomyopathies; Cocaine; Nifedipine; Nitrendipine; Rats; Rats, Inbred Strains | 1985 |